Annual Retained Earnings
-$116.42 M
-$60.39 M-107.77%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual retained earnings is currently -$116.42 million, with the most recent change of -$60.39 million (-107.77%) on 31 December 2023. During the last 3 years, it has fallen by -$107.80 million (-1250.27%). ACRV annual retained earnings is now -1250.27% below its all-time high of -$8.62 million, reached on 01 December 2020.ACRV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$174.15 M
-$22.44 M-14.79%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly retained earnings is currently -$174.15 million, with the most recent change of -$22.44 million (-14.79%) on 30 September 2024. Over the past year, it has dropped by -$76.98 million (-79.22%). ACRV quarterly retained earnings is now -600.36% below its all-time high of -$24.86 million, reached on 01 December 2021.ACRV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -107.8% | -79.2% |
| 3 y3 years | -1250.3% | -600.4% |
| 5 y5 years | - | - |
ACRV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1250.3% | at low | -600.4% | at low |
| 5 y | 5 years | -1250.3% | at low | -600.4% | at low |
| alltime | all time | -1250.3% | at low | -600.4% | at low |
Acrivon Therapeutics Common Stock Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$174.15 M(+14.8%) |
| June 2024 | - | -$151.70 M(+14.1%) |
| Mar 2024 | - | -$132.91 M(+14.2%) |
| Dec 2023 | -$116.42 M | -$116.42 M(+19.8%) |
| Sept 2023 | - | -$97.17 M(+17.5%) |
| June 2023 | - | -$82.70 M(+20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$68.79 M(+22.8%) |
| Dec 2022 | -$56.03 M(+125.3%) | -$56.03 M(+19.0%) |
| Sept 2022 | - | -$47.10 M(+24.3%) |
| June 2022 | - | -$37.91 M(+52.4%) |
| Dec 2021 | -$24.86 M(+188.4%) | - |
| Dec 2021 | - | -$24.86 M |
| Dec 2020 | -$8.62 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual retained earnings?
- What is the all time high annual retained earnings for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual retained earnings year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly retained earnings?
- What is the all time high quarterly retained earnings for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly retained earnings year-on-year change?
What is Acrivon Therapeutics Common Stock annual retained earnings?
The current annual retained earnings of ACRV is -$116.42 M
What is the all time high annual retained earnings for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual retained earnings is -$8.62 M
What is Acrivon Therapeutics Common Stock annual retained earnings year-on-year change?
Over the past year, ACRV annual retained earnings has changed by -$60.39 M (-107.77%)
What is Acrivon Therapeutics Common Stock quarterly retained earnings?
The current quarterly retained earnings of ACRV is -$174.15 M
What is the all time high quarterly retained earnings for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly retained earnings is -$24.86 M
What is Acrivon Therapeutics Common Stock quarterly retained earnings year-on-year change?
Over the past year, ACRV quarterly retained earnings has changed by -$76.98 M (-79.22%)